Terms: = Endocrine gland cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
4 results:
1. Prognostic Effect of Preoperative Inflammatory Markers on Morbidity and Overall Survival in Pancreatic Adenocarsinoma.
Çaparlar MA; Durhan A; Süleymanov M; Binarbaşı C; Koşmaz K
Niger J Clin Pract; 2023 Dec; 26(12):1902-1909. PubMed ID: 38158359
[TBL] [Abstract] [Full Text] [Related]
2. High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic cancer.
Ischyropoulou M; Sabljo K; Schneider L; Niemeyer CM; Napp J; Feldmann C; Alves F
Adv Mater; 2023 Nov; 35(46):e2305151. PubMed ID: 37587542
[TBL] [Abstract] [Full Text] [Related]
3. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
[TBL] [Abstract] [Full Text] [Related]
4. Determining Patient Preferences for Indeterminate Thyroid Nodules: Observation, Surgery or Molecular Tests.
Lee DJ; Xu JJ; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Rotstein LE; Goldstein DP; de Almeida JR
World J Surg; 2017 Jun; 41(6):1513-1520. PubMed ID: 28175931
[TBL] [Abstract] [Full Text] [Related]